BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37989688)

  • 21. Predicting outcomes following second intent healing of periocular surgical defects.
    Kibbi N; Khan Y; Leffell DJ; Christensen SR; Suozzi KC
    Arch Dermatol Res; 2021 Aug; 313(6):483-489. PubMed ID: 32833078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mohs Surgery for Periocular Tumors.
    Monheit G; Hrynewycz K
    Dermatol Surg; 2019 Dec; 45 Suppl 2():S70-S78. PubMed ID: 31764293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multicentre review of the histology of 1012 periocular basal cell carcinomas.
    Lin Z; Qidwai U; Igali L; Hemmant B
    Eur J Ophthalmol; 2021 Sep; 31(5):2699-2704. PubMed ID: 32907383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Appropriate use criteria for basal cell carcinoma Mohs surgery at a single center in the face of high-burden skin cancer: a retrospective cohort study.
    Fantini BC; Bueno Filho R; Chahud F; Souza CDS
    J Dermatolog Treat; 2019 Feb; 30(1):74-80. PubMed ID: 29727201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive Value of Preoperative Periocular Skin Cancer Measurements for Final Mohs Defect Size.
    Scofield-Kaplan SM; Jackson C; Gurney T; McDonnell E; Mancini R
    Ophthalmic Plast Reconstr Surg; 2019; 35(6):604-608. PubMed ID: 31206459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrospective audit of patients referred for further treatment following Mohs surgery for non-melanoma skin cancer.
    Wee E; Goh MS; Estall V; Tiong A; Webb A; Mitchell C; Murray W; Tran P; McCormack CJ; Henderson M; Hiscutt EL
    Australas J Dermatol; 2018 Nov; 59(4):302-308. PubMed ID: 29349770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of basal cell carcinoma subtype with histologically confirmed subclinical extension during Mohs micrographic surgery: A prospective multicenter study.
    Lim GF; Perez OA; Zitelli JA; Brodland DG
    J Am Acad Dermatol; 2022 Jun; 86(6):1309-1317. PubMed ID: 35231546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth of periocular basal cell carcinomas.
    Tan E; Lin FP; Sheck LH; Salmon PJ; Ng SG
    Br J Dermatol; 2015 Apr; 172(4):1002-7. PubMed ID: 25308051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of 24 cases of Mohs surgery and ophthalmic plastic reconstruction.
    Kumar B; Roden D; Vinciullo C; Elliott T
    Aust N Z J Ophthalmol; 1997 Nov; 25(4):289-93. PubMed ID: 9395832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Linear basal cell carcinoma: a distinct clinical entity in the periocular region.
    Mavrikakis I; Malhotra R; Barlow R; Huilgol SC; Selva D
    Ophthalmology; 2006 Feb; 113(2):338-42. PubMed ID: 16406534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basal cell carcinoma of the periocular region.
    Arlette JP; Carruthers A; Threlfall WJ; Warshawski LM
    J Cutan Med Surg; 1998 Apr; 2(4):205-8. PubMed ID: 9558303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low recurrence rate of head and neck basal cell carcinoma treated with Mohs micrographic surgery: A retrospective study of 1021 cases.
    Kuiper EM; van den Berge BA; Spoo JR; Kuiper J; Terra JB
    Clin Otolaryngol; 2018 Oct; 43(5):1321-1327. PubMed ID: 29953746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mohs micrographic surgery versus wide local excision for eyelid melanoma: An analysis of a national database.
    Ramachandran V; Phan K
    J Plast Reconstr Aesthet Surg; 2022 Dec; 75(12):4410-4415. PubMed ID: 36257889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrence rates of periocular basal cell carcinoma following intra-operative en-face frozen section margin controlled excision.
    McCabe GA; Mulcahy LT; Mulligan N; Fulcher T
    Ir J Med Sci; 2024 Jun; 193(3):1209-1213. PubMed ID: 38289579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrence rates following surgical excision of periocular basal cell carcinomas: systematic review and meta-analysis.
    Phan K; Oh LJ; Goyal S; Rutherford T; Yazdabadi A
    J Dermatolog Treat; 2020 Sep; 31(6):597-601. PubMed ID: 31769708
    [No Abstract]   [Full Text] [Related]  

  • 36. Periocular basal cell carcinoma: 5-year outcome following Slow Mohs surgery with formalin-fixed paraffin-embedded sections and delayed closure.
    Morris DS; Elzaridi E; Clarke L; Dickinson AJ; Lawrence CM
    Br J Ophthalmol; 2009 Apr; 93(4):474-6. PubMed ID: 19060015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Australian Mohs database: periocular squamous intraepidermal carcinoma.
    Malhotra R; James CL; Selva D; Huynh N; Huilgol SC
    Ophthalmology; 2004 Oct; 111(10):1925-9. PubMed ID: 15465558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
    Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
    J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mohs' micrographic surgery for basal cell carcinomas on the eyelids and medial canthal area. II. Reconstruction and follow-up.
    Lindgren G; Lindblom B; Larkö O
    Acta Ophthalmol Scand; 2000 Aug; 78(4):430-6. PubMed ID: 10990046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical margins required for basal cell carcinomas treated with Mohs micrographic surgery according to tumor features.
    Cerci FB; Kubo EM; Werner B; Tolkachjov SN
    J Am Acad Dermatol; 2020 Aug; 83(2):493-500. PubMed ID: 32289390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.